HCBD-Pro Services
Client Subscribers
HIPN Daily Archive
No Password Required
HIPN Daily SignUp
free e-newsletter
No Password Required
Current Headlines
No Password Required
Events Calendar
No Password Required
HCBD-PRO Services
Search Companies
Search People
Search News|Events
Query News -
By Companies
By People
HR Announcements
Health Plan Industry
MailingList Rental
HCBD-EmailSend
Broadcast Email
HCBD Journalist Wire
News Distribution
Website | e-newsletter
Online Advertising
Trade Conf | Webinar
Event Promotion
Welcome <Guest>
Login
Echosens North America
Company Website:
http://www.echosens.us
Newsroom
Business Focus:
Clinical Information Systems
Disease Management
Disease Management: Web-Based Solutions
Company Description:
Echosens is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases.
Company Officials:
Jon Gingrich
Client Login Required
Login
Become a Client
[Chief Executive Officer]
Dominique Legros
Client Login Required
Login
Become a Client
[Group CEO]
Laurent Sandrin
Client Login Required
Login
Become a Client
[Chairman and Chief Technology Officer]
View Additional Employees and Representatives
Mary Spardel
Client Login Required
Login
Become a Client
[PR Agency Representative]
Company News/Coverage:
CBS News "Global Thought Leaders" Series Features Echosens: Video Showcases FibroScan as Medical Gold Standard
Echosens Appoints Medical Equipment Expert Jo Massoels as Chief Marketing Officer, Expands Global Marketing of FibroScan to Halt Liver Disease Epidemic
Echosens Ranks Among PM360’s Leading Innovative Companies for 9th Annual Innovations Issue, Demonstrates Ingenuity During COVID-19 Pandemic
Echosens Partners with Gastrologix to Provide Independent GI Practices with FibroScan for Non-Invasive, Cost-effective Liver Health Examinations
Echosens Launches Collaborative Relationship With Healthy Trucking of America: Improves Liver Health, Safety and Productivity of Nation’s Professional Drivers
View all remaining Company News/Coverage headlines
Echosens Announces Acceptance of Actuarial Study in American Journal of Managed Care: Positive Return on Investment of VCTE/CAP FibroScan Technology to Measure Liver Fat and Stiffness
ChronWell, ModifyHealth and Echosens North America Partner to Create LIVErHEALTHY Program for Managing Liver Disease
Echosens Highlights Link Between Diabetes and Liver Disease, Urges Non-Invasive Detection and Monitoring of Liver Fat to Halt Disease Progression
Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement
Echosens Supports October 2020 Liver Cancer Awareness Month: Cites Link to Nonalcoholic Fatty Liver Disease and Importance of Early Detection
Echosen: Boost Workforce Productivity, Reduce Medical Costs: Integrate Echosens’ FibroScan Into MetaPhy’s Chronic Care Liver Disease Management Program
Echosens Emphasizes Critical Need to Monitor Liver Health, Identify Those Living with Silent Disease and Provide Follow-Up for Hepatitis C Virus
Echosens Announces NICE, UK Health Technology Assessment Organization, Issues MedTech Innovation Briefing on FibroScan Liver Exam in Primary Care
Integrating Echosens’ FibroScan into MetaPhy’s Chronic Care Liver Disease Management Program Impacts Patient Outcomes, Costs, Financial Performance of Gastroenterology Practices
Echosens and NASHNET Recognize International NASH Day, June 12, 2020: Collaboration, Best Practices and Early Detection of Fatty Liver Disease
Battle Fatty Liver Disease and Obesity, Inform Cost-Effective Treatment Decisions: Echosens Articulates Value of Non-Invasive Diagnostic Tool, FibroScan
Echosens: CDC Calls for Universal Hepatitis C Screening to Halt Advanced Liver Disease & Liver Cancer
Echosens and MetaPhy Health Collaborate to Expand Patient-Centered Care for Chronic Liver Conditions: Gastroenterology Specialists Improve Outcomes, Lower Costs & Enhance Practice Performance
Echosens Engages Santa Barbara Actuaries to Demonstrate Cost-effectiveness of FibroScan Non-invasive Technology for Measuring Liver Fat and Stiffness, Answers Payer Needs to Address NAFLD and NASH Epidemic
Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement (SSM by VCTE) for Risk Stratification of Patients With Advanced Chronic Liver Disease
Study Validating Echosens FibroScan FAST Score for Cost-Effective, Efficient Identification of People at Risk for Active Fibrotic NASH Published in Lancet Gastroenterology & Hepatology
Echosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Echosens Calls for Increased Vigilance by Healthcare Providers to Monitor Liver Health at Point of Care, Address Obesity, Diabetes and Halt Progression of NAFLD
Echosens at VA’s National Veterans Small Business Engagement Meeting: Demonstrating FibroScan Benefits for Early Detection and Monitoring of Liver Disease
Echosens FAST Score Revolutionizes the Assessment of NASH: Cost-Effective, Efficient Identification of Individuals at Risk for Active Fibrotic NASH
Echosens Supports October 2019 Liver Cancer Awareness Month: Cites Importance of Early Detection of Nonalcoholic Fatty Liver Disease
Echosens Releases White Paper: Addressing Risk for Cirrhosis, Liver Failure and Liver Cancer Among America’s Veterans
Echosens Releases White Paper: Federally Qualified Health Centers Effectively Address Alarming Rise in Liver Disease
Echosens North America Names Jon Gingrich as CEO: Global Medical Device Business Executive Leads Strategic US Company Growth Strategy in Liver Disease Assessment
Echosens Appoints Dominique Legros as Group CEO: Global Healthcare Business and Technology Expert Leads Company Growth in Chronic Liver Disease Assessment
Eradicating Hepatitis C and Fatty Liver Disease: VA Broadens Contract with Echosens to Include FibroScan 430 Portable Technology, Expands Access to Screening and Early Detection
HCV Treatments Can Cure Viral Infection, Not Necessarily Liver Disease, Advises Echosens to Emphasize Importance of Monitoring Liver Health
The Economic Tsunami of Liver Disease: Echosens Publishes New White Paper, Highlights Impact on U.S. Financial Solvency
Echosens and NASHNET Recognize International NASH Day: Increased Education and Early Detection of Fatty Liver Disease
Echosens White Paper: Looming Epidemic - Non-alcoholic Fatty Liver Disease
Echosens North America Publishes New White Paper: Looming Epidemic of Non-Alcoholic Fatty Liver Disease
About Us
|
Purchase Pro
|
Contact Us
© 2006-2010 Healthcare BizDev, Inc. All rights reserved.
Privacy Policy
|
Legal Conditions